The Pentagon won't say what research backs the policy
In a move that blurs the line between medical care and ideological ambition, the Pentagon has announced mandatory testosterone screening for older service members and voluntary testing for younger troops, with access to replacement therapy for those who test low. The policy, championed by Defense Secretary Pete Hegseth, arrives in the shadow of documented performance-enhancing drug abuse within elite units and a recruit's death in 2022. It also unfolds alongside a broader Trump administration effort to loosen federal restrictions on testosterone prescriptions — suggesting that what is framed as military readiness may be inseparable from a wider cultural project around masculinity and wellness. How a democracy balances the health of its defenders against the ideologies of those who command them is a question this program has not yet answered.
- A Pentagon-wide testosterone screening mandate is now in motion, touching nearly every active-duty service member — yet the scientific basis for the policy remains publicly unaccounted for.
- The announcement lands against a charged backdrop: Navy SEAL units have faced years of scrutiny over performance-enhancing drug abuse, and a recruit died in 2022 after using testosterone and other substances.
- Democratic lawmakers — several of them veterans — are calling the program ideologically driven, with one labelling it 'gender-affirming care' in a pointed rebuke of Hegseth's opposition to transgender troops.
- Female service members are conspicuously absent from the policy's equity framework, with no mention of estrogen-based therapy for women entering perimenopause, despite documented military infertility disparities.
- The initiative sits within a broader administration push to loosen FDA restrictions on testosterone products, raising questions about whether military health policy is being shaped by the 'manosphere' wellness movement rather than medical evidence.
- Weeks after Hegseth repealed the military's flu vaccine mandate on autonomy grounds — preceding a boot camp outbreak that sickened hundreds — the pattern of ideology outpacing epidemiology is becoming difficult to ignore.
The Pentagon is rolling out a testosterone screening program that will reach nearly every active-duty service member. Defense Secretary Pete Hegseth announced the initiative online, framing it as a readiness measure: troops under 30 may volunteer for testing, while those 30 and older will face mandatory screening during annual medical reviews. Those who test low will have access to replacement therapy, though the Pentagon has offered little clarity on which medical conditions would qualify — gesturing only toward keeping troops "strong, resilient and capable."
The announcement arrives against a troubled backdrop. Navy SEALs have faced years of scrutiny over testosterone and performance-enhancing drug use. In 2022, a SEAL recruit died during training and was later found to have been using testosterone alongside other substances — a discovery that revealed substance abuse was far more widespread in the program than previously acknowledged. Hegseth insists the new program is "not about artificial enhancement," a distinction that sits uneasily given the timing. When asked what research informed the policy, the Pentagon declined to respond.
The program's equity gaps have drawn sharp criticism. There is no mention of estrogen-based therapy for female service members entering perimenopause, a significant omission given that military women experience higher rates of infertility than their civilian counterparts. Senator Tammy Duckworth, an Iraq War veteran, called the policy "gender-affirming care" — a deliberate inversion of Hegseth's own rhetoric against transgender troops. Representative Chrissy Houlahan said it proved Hegseth "takes direction from the far corners of the manosphere." Both lawmakers have called for hormone screening to be extended equitably to all service members.
The initiative is part of a wider Trump administration effort to make testosterone more accessible. Health Secretary Robert F. Kennedy Jr. has been pushing to ease federal prescription restrictions, and the FDA recently proposed loosening limits on testosterone gels, patches, pills, and injections — products currently approved only for men with clinically diagnosed hypogonadism. Within the administration's wellness orbit, testosterone has been promoted as a broad-spectrum remedy for aging, muscle loss, and mental sharpness — claims most medical experts do not endorse.
The testosterone program follows Hegseth's repeal of the military's flu vaccine mandate, justified on grounds of medical autonomy — a decision that preceded a June flu outbreak at an Air Force boot camp that sickened hundreds of recruits. Together, these decisions sketch a Pentagon leadership willing to reshape military health policy around ideological commitments. Whether the testosterone program will prove medically sound or follow a similar pattern — announced with confidence, built on uncertain ground — remains an open question.
The Pentagon is rolling out a new testosterone screening program that will touch nearly every active-duty service member in the coming years. Defense Secretary Pete Hegseth announced the initiative in a social media video, framing it as a way to keep troops operating at peak performance. The mechanics are straightforward: soldiers under 30 can volunteer for testosterone testing, while those 30 and older will face mandatory screening as part of their annual medical checkups. Those who test low will have access to testosterone replacement therapy, though the Pentagon has been vague about which conditions the treatment would address, pointing only to Hegseth's language about keeping troops "strong, resilient and capable" in the face of modern warfare's demands.
The announcement arrives against a backdrop of documented problems within elite military units. Navy SEALs have faced years of scrutiny over their use of testosterone and similar performance-enhancing substances. In 2022, a SEAL recruit died during training, and investigators subsequently discovered he had been using testosterone along with other drugs. The discovery revealed that substance abuse was far more widespread in the program than previously known. A year later, the Navy responded by launching its own drug-testing initiative specifically designed to catch testosterone and related compounds. Hegseth insists his new program is "not about artificial enhancement," a distinction that sits uneasily with the timing and context.
What remains unclear is whether the Pentagon has any scientific foundation for the policy. When asked what research or academic studies informed the decision, the Pentagon declined to respond. The program's scope also raises questions about equity. The announcement does not specify whether female service members would be eligible for estrogen-based therapy as they enter perimenopause, a significant omission given that military women face higher rates of infertility than the civilian population, according to studies cited by Democratic lawmakers.
The testosterone initiative is part of a broader Trump administration push to make the hormone more accessible. Health Secretary Robert F. Kennedy Jr. and other officials have been working to ease restrictions on testosterone prescriptions. Last month, the Food and Drug Administration proposed loosening limits on testosterone gels, pills, patches, and injections. Currently, FDA labeling restricts these medications to men with hypogonadism, a condition causing severely depressed testosterone levels. But within Kennedy's "Make America Healthy Again" movement, testosterone has become a kind of wellness panacea—promoted as a way to look younger, build muscle, and sharpen mental function, claims that most medical experts do not endorse. Recent studies have offered some support for testosterone's benefits in certain conditions and have eased concerns about heart safety, leading the FDA to remove a warning about heart attack and stroke risks last year.
Democratic lawmakers have seized on the announcement as ideologically motivated rather than medically grounded. Senator Tammy Duckworth, an Iraq War veteran, called it "gender-affirming care"—a pointed jab at Hegseth's opposition to transgender troops. Representative Chrissy Houlahan, an Air Force veteran, said the policy "proves that Secretary Hegseth takes direction from the far corners of the manosphere." Both lawmakers have called on Hegseth to extend hormone screening to all service members, male and female, to identify fertility problems early. Hegseth's record on gender issues in the military is contentious. He has previously stated that women should not hold combat roles and that such positions should meet the "highest male standard." Since taking office, he has blocked some promotions for women and fired female leaders.
The testosterone announcement also comes weeks after Hegseth repealed the military's long-standing flu vaccine mandate, citing "medical autonomy" and religious freedom. That decision preceded a flu outbreak at an Air Force boot camp in June that sickened hundreds of recruits. The pattern suggests a Pentagon leadership willing to reshape military health policy around ideological commitments rather than epidemiological evidence. Whether the testosterone program will follow a similar trajectory—announced with confidence but lacking rigorous scientific underpinning—remains to be seen.
Notable Quotes
The program is 'not about artificial enhancement'— Defense Secretary Pete Hegseth
The announcement sounds 'like gender-affirming care,' and lawmakers called for hormone screenings to be extended to all service members to identify fertility issues early— Senator Tammy Duckworth and Representative Chrissy Houlahan
The Hearth Conversation Another angle on the story
Why announce a testosterone screening program now, and why make it mandatory for troops over 30?
The Pentagon frames it as readiness—keeping soldiers at their best. But the timing matters. There's been years of pressure around performance-enhancing drugs in special operations, and a SEAL recruit died in 2022 using testosterone. This feels like an attempt to legitimize and systematize something that was already happening in the shadows.
Is this actually about medical care, or is it political?
That's the question everyone's asking. The Pentagon won't say what research backs the policy. They won't clarify if women get access to hormone therapy too. Meanwhile, the Trump administration is simultaneously pushing the FDA to make testosterone easier to prescribe. It looks coordinated, not evidence-based.
What do military doctors think?
We don't know. The Pentagon hasn't released any internal medical guidance or expert consensus. That silence is telling. If this were grounded in solid medicine, they'd probably say so.
How does this fit with Hegseth's other decisions?
He repealed the flu vaccine mandate weeks before a flu outbreak hit an Air Force boot camp and infected hundreds of people. He's blocked promotions for women and fired female leaders. The testosterone program doesn't exist in isolation—it's part of a pattern of reshaping military policy around ideology rather than data.
What happens to service members who don't want the screening?
For those under 30, it's voluntary. But at 30 and above, it becomes mandatory during annual medical reviews. That's a significant shift in medical autonomy for older troops, which is ironic given Hegseth's rhetoric about freedom and choice.